MED
MEDIFAST INC
NYSE · Consumer Cyclical · Personal Products & Services · US
$12.18
−0.69%Oct 27, 2026, 17:01 UTC
MEDIFAST INC reported third-quarter results that exceeded earnings expectations, with coach productivity up 54.1% and margins expanding despite declining revenue and a shrinking coach network.
Source:Oct 26, 2026, 14:16 UTC
MEDIFAST INC reported a quarterly loss of $0.19 per share, compared with a loss of $0.21 per share a year earlier.
Source:Oct 26, 2026, 12:12 UTC
Medifast reported third-quarter 2026 revenue of $72.0 million, a net loss of $17.5 million and diluted loss per share of $1.57, and forecast full-year 2026 diluted loss per share of $1.80 to $2.05.
Source:Oct 14, 2026, 20:05 UTC
MEDIFAST INC said it will announce financial results for the quarter ended September 30, 2026, on October 26, 2026, before market open.
Source:Aug 27, 2026, 12:30 UTC
Medifast, Inc. launched the Medifast Metabolic Health Institute to advance metabolic health through research and evidence-based education, consolidating its clinical research and scientific expertise under one body.
Source:Aug 3, 2026, 20:05 UTC
Medifast reported its financial results for the second quarter ended June 30, 2026, including revenue of $76.4 million, a net loss of $3.1 million, and cash and investments of $169.8 million.
Jul 17, 2026, 12:30 UTC
Medifast, Inc. launched Trilivy, a science-backed metabolic health system including newly formulated meal replacements with MetaVantage Technology.
Source:Jun 1, 2026, 00:00 UTC
Jason L. Groves resigned as Chief Legal Officer & Corporate Secretary of Medifast Inc, effective May 29, 2026.